Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Barcelona wants to close an important contract in January

Barcelona are currently busy trying to register Dani Olmo and Pau Víctor as a matter of status this January, but have other important matters planned for this month. As well as chasing Bayer Leverkusen’s Jonathan Tah, Barcelona will try to sign Pedri to a new contract.

According to Sport, Barcelona intends to close this month a new contract for the Canarian until 2030. Once the drama of the registrations of Olmo and Víctor has been resolved, Barcelona, ​​​​now in a situation of improving the salary limit after the sale of 100 million VIP boxes for the next 20 years at the Camp Nou, will seek to announce the Pedri operation, with talks for Gavi and Ronald Araujo to follow. They will also announce the agreement already agreed upon by Marc Bernal. The Catalan newspaper points out that Pedri is one of the few ‘untouchables’ currently in the Barça squad.

Regardless of tying Pedri down for four more years, that good news will be lost for Barcelona fans if they can’t play Olmo or Víctor for the rest of the season. However, the 22-year-old has been omnipresent for Hansi Flick this season, and his return to form has been the driving force behind his good form to start the season.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.